Bhagyashree Thakre

Bhagyashree Thakre

Auto-generated profile, based on publicly available information

Bhagyashree Thakre

Biogenix G42 Lab

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SMSally Mahmoud
Sally Mahmoud
SGsubhashini ganesan
subhashini ganesan
EIEsra Ibrahim
Esra Ibrahim
BTBhagyashree Thakre
Bhagyashree Thakre
JTJuliet G. Teddy
Juliet G. Teddy
WAWalid Z. Abbas
Walid Z. Abbas
In this COVID‐19 pandemic, there is a dire need for cost‐effective and less time‐consuming alternatives for SARS‐CoV‐2 testing. The RNA extraction‐free method for detecting SARS‐CoV‐2 in saliva is a promising option. This study found that it has high sensitivity (85.34%), specificity (95.04%), and was comparable to the gold standard nasopharyngeal swab (NPS) sample tests. The method showed good agreement between salivary and NPS samples, with a kappa coefficient of 0.797. However, there are variations in the sensitivity and specificity based on the RT‐PCR kit used. The Thermo Fisher Applied Biosystems showed high sensitivity, positive predictive value (PPV), and negative predictive value (NPV) but also showed a higher percentage of invalid reports. On the other hand, the BGI kit showed high specificity, better agreement (kappa coefficient) between the results of saliva and NPS samples, and higher correlation between the Ct values of saliva and NPS samples. Thus, the RNA extraction‐free method for salivary sample serves as an effective alternative screening method for COVID‐19.